Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Vericiguat (Verquvo) for Heart Failure With Reduced Ejection Fraction.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
  • معلومة اضافية
    • الموضوع:
      ALDOSTERONE antagonists; LEVOSIMENDAN; HEART failure
    • نبذة مختصرة :
      The article offers information on vericiguat (Verquvo) for the treatment of heart failure (HF) with reduced ejection fraction. Treatment options for the condition include diuretic, angiotensin receptor-neprilysin inhibitor and beta blocker. The drug vericiguat was approved by the U.S. Food and Drug Administration on January 20, 2021 for adults with symptomatic HF. The drug's safety, efficacy and dosing and administration are discussed.